- Reaction score
- 452
Nobody should be expecting the trial results. It's very unlikely we'll hear them anytime soon, and Shiseido doesn't seem to be in a hurry to hand them over to RepliCel. Especially if they have a working, marketable product.
If not for RepliCel, the odds of any of us ever knowing the results of the trial would be basically 0. The only reason RepliCel publicly divulges such information at all is because they desperately want to attract investors. Shiseido is not concerned with that.
Cosmetic companies are constantly running new things through trials and never talk about them publicly. Because A: Competitors are watching, and B: Nobody gives a sh*t but us, and some guys in suits.
I agree. Shiseido never gave the 2018 time frame for market. Also, I don't believe they are required to make the results public to get approval to commercialize. We may not hear about the results until after release which may still be a ways out.
Remember this document? https://www.shiseidogroup.com/news/detail.html?n=00000000002396
It's the 3 year plan 2018 -2020.
3. New Value Creation through Innovation
By merging our own knowledge and experience with the capabilities of acquired brands and technologies together with the high expertise of talented people we will not only produce innovation in cosmetics but also build innovative business models and explore new frontiers such as artificial skin, hair and skin regeneration, and advanced beauty care. Furthermore we will increase the number of R&D personnel to 1,500 and aim for R&D investment-to-sales ratio of 3% by 2020. In order to maximize R&D capabilities on a global level, the “Global Innovation Center” will start its operations in Yokohama Minato Mirai 21, from December 2018, as a hub for all our innovation centers around the world.
This is a time frame provided by Shiseido. Although it doesn't specifically state commercialize, If by after 2020 nothing comes from RCH-01 from Shiseido, then maybe one could say they have abandoned it but until then, I feel it is highly unlikely.
They built an entire facility in Kobe for the sole purpose of RCH-01 research and commercialization. It is unlikely they would invest so much into RCH-01 unless they knew it would work.
https://www.shiseidogroup.com/releimg/2289-e.pdf
I think all the disappointment is due to Lee Buckler's false and made up timelines.
